Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95

Abstract

Objective: Microalbuminuria is a renal marker of general vascular endothelial damage and early atherosclerosis with adverse prognostic implications. Microalbuminuria is associated with diabetes, insulin resistance, central adiposity and hypertension. We evaluated the degree of the association of components of the metabolic syndrome with microalbuminuria in a subsample of a non-diabetic study population.

Design: Men and women aged 25–74 living in the city of Augsburg, Germany, were interviewed and examined in a standardised manner at a population-based survey conducted in 1994/95. Persons with a history of diabetes or HbA1c level 7% were excluded.

Outcome: Albumin and creatinine were determined quantitatively in a spot urine and defined as microalbuminuria via an albumin/creatinine ratio between 30 and 299 mg/g.

Results: Among 920 men and 879 women, the age- standardised prevalence of microalbuminuria was 8.0% and 7.5%, respectively. While a graded, positive increase in prevalence of microalbuminuria across quintiles of waist-to-hip (WHR) was observed in non-hypertensive men and women, microalbuminuria was uniformly high among hypertensives. Multivariate logistic regression models showed that central adiposity (OR 3.3) or hypertension (OR 4.0) alone significantly increased the odds of microalbuminuria while their joint presence (OR 3.6) did not add to the occurrence of microalbuminuria. While obesity was not associated with microalbuminuria once central adiposity was taken into account, elevated percent body fat remained associated with microalbuminuria.

Conclusions: Signs of early endothelial dysfunction as manifested as microalbuminuria are strongly and independently associated with central adiposity and should be considered in the context of the metabolic or insulin resistance syndrome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Deckert T et alAlbuminuria reflects widespread vascular damage. The Steno hypothesis Diabetologia 1989 32 219–226

    Article  CAS  Google Scholar 

  2. Bianchi S, Bigazzi R, Campese VM Microalbuminuria in essential hypertension J Nephrol 1997 10 216–218

    CAS  PubMed  Google Scholar 

  3. Mykkänen L et alMicroalbuminuria is associated with insulin resistance in nondiabetic subjects. The Insulin Resistance Atherosclerosis Study Diabetes 1998 47 793–800

    Article  Google Scholar 

  4. Scaglione R et alCentral obesity and hypertension: pathophysiologic role of renal haemodynamics and function Int J Obes Relat Metab Disord 1995 19 403–409

    CAS  PubMed  Google Scholar 

  5. Liese AD, Mayer-Davis EJ, Haffner SM Development of the multiple metabolic syndrome: an epidemiologic perspective Epidemiol Rev 1998 20 157–172

    Article  CAS  Google Scholar 

  6. WHO MONICA Project Principal Investigators The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration J Clin Epidemiol 1988 41 105–114

    Article  Google Scholar 

  7. WHO MONICA Projekt Augsburg Survey Sampling. GSF-Bericht 31/86 Neuherberg, Germany 1986

    Google Scholar 

  8. WHO MONICA Projekt Augsburg Manual of Operations. GSF-Bericht 20/85 Neuherberg, Germany 1985

    Google Scholar 

  9. WHO MONICA project The WHO MONICA Manual Cardiovascular Disease Unit, Geneva, WHO Geneva 1990

    Google Scholar 

  10. Keil U et alThe cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85 Acta Med Scand Suppl 1988 728 119–128

    CAS  PubMed  Google Scholar 

  11. Schwab SJ, Christensen RL, Dougherty K, Klahr S Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples Arch Intern Med 1987 147 943–944

    Article  CAS  Google Scholar 

  12. Segal KR et alLean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study Am J Clin Nutr 1988 47 7–14

    Article  CAS  Google Scholar 

  13. Nelson RG et alAssessment of risk of overt nephropathy in diabeticpatients from albumin excretion in untimed urine specimens Arch Intern Med 1991 151 1761–1765

    Article  CAS  Google Scholar 

  14. Chiarelli F, Verrotti A, Mohn A, Morgese G The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications Ann Med 1997 29 439–445

    Article  CAS  Google Scholar 

  15. World Health Organization. WHO Expert Committee on physical status: the use and interpretation of anthropometry. Geneva, Switzerland. World Health Organization Technical Report Series 1995

  16. Peters AL, Davidson MB, Schriger DL, Hasselblad V, for the Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels JAMA 1996 276 1246–1252

    Article  CAS  Google Scholar 

  17. Valensi P et alMicroalbuminuria in obesepatients with or without hypertension Int J Obes Relat Metab Disord 1996 20 574–579

    CAS  PubMed  Google Scholar 

  18. Basdevant A et alMicroalbuminuria and body fat distribution in obese subjects Int J Obes Relat Metab Disord 1994 18 806–811

    CAS  PubMed  Google Scholar 

  19. Foyle W-J, Carstensen E, Fernández MC, Yudkin JS Longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium-lithium countertransport in nondiabetic subjects Arterioscler Thromb Vasc Biol 1995 15 1330–1337

    Article  CAS  Google Scholar 

  20. Reid M, Bennet F, Wilks R, Forrester T Microalbuminuria, renal function and waist:hip ratio in black hypertensive Jamaicans J Hum Hypertens 1998 12 221–227

    Article  CAS  Google Scholar 

  21. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease Circulation 1995 91 831–837

    Article  CAS  Google Scholar 

  22. Liese AD et alElevated fasting insulin predicts incident hypertension: the ARIC study J Hypertens 1999 17 1169–1177

    Article  CAS  Google Scholar 

  23. Yudkin JS, Forrest RD, Jackson CA Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey Lancet 1988 2 530–533

    Article  CAS  Google Scholar 

  24. Mykkänen L et alMicroalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS) Stroke 1997 28 1710–1716

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the contribution of Andrea Schneider for data management and verification and the staff of the MONICA Augsburg 1994/95 survey.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to AD Liese.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liese, A., Hense, HW., Döring, A. et al. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 15, 799–804 (2001). https://doi.org/10.1038/sj.jhh.1001266

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001266

Keywords

This article is cited by

Search

Quick links